Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAPGEF4 | Q8WZA2 | 3/20 | 0.46 |
| ▸ | PGK1 | P00558 | 1/20 | 0.41 |
| ▸ | PGK2 | P07205 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | CES2 | O00748 | 1/20 | 0.37 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.37 |
| ▸ | XPO1 | O14980 | 2/20 | 0.35 |
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.34 |
| ▸ | IDO1 | P14902 | 2/20 | 0.33 |
| ▸ | IKBKB | O14920 | 1/20 | 0.33 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.33 |
| ▸ | TMPRSS4 | Q9NRS4 | 1/20 | 0.33 |
| ▸ | IDH1 | O75874 | 1/20 | 0.33 |
| ▸ | RXRA | P19793 | 1/20 | 0.33 |
| ▸ | RXRB | P28702 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15338946 | 1.00 | RAPGEF4 (0.46) | RAPGEF4PGK1PGK2MAPTCES2 | |
| SCHEMBL383565 | 0.88 | CES2 (0.44) | RAPGEF4MAPTCES2XPO1IDO1 | |
| SCHEMBL10271930 | 0.85 | CES2 (0.42) | RAPGEF4MAPTCES2XPO1IDO1 | |
| SCHEMBL16823330 | 0.85 | CES2 (0.42) | RAPGEF4MAPTCES2XPO1IDO1 | |
| SCHEMBL16861287 | 0.85 | CES2 (0.42) | RAPGEF4MAPTCES2XPO1IDO1 | |
| SCHEMBL15329899 | 0.85 | CES2 (0.42) | RAPGEF4MAPTCES2XPO1IDO1 | |
| SCHEMBL107119 | 0.85 | RAPGEF4 (0.56) | RAPGEF4PGK1PGK2MAPTCES2 | |
| Hydrochloric Acid SCHEMBL9552697 | 0.85 | CYP3A4 (0.43) | RAPGEF4PGK1PGK2NOTUMTAS2R14 | |
| SCHEMBL16351489 | 0.83 | RAPGEF4 (0.43) | RAPGEF4PGK1PGK2MAPTCES2 | |
| SCHEMBL15293395 | 0.80 | RAPGEF4 (0.39) | RAPGEF4PGK1PGK2MAPTTAS2R14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3543007-B1 | LAMINATE | DAIKIN IND LTD (JP) | 2023-11-22 | — | — | EP | disclosed |
| US-20230365607-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-11-16 | — | — | US | disclosed |
| US-11746122-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11746122-B2 | Organic electroluminescent materials and devices | GLRA3, GLRA2, LIFR | RAPGEF4 902/4885PGK1 3839/4885PGK2 3570/4885 |
| US-20230365607-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, OR10J3 | RAPGEF4 1102/4885PGK1 3623/4885PGK2 3359/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.